High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. [electronic resource]
Producer: 20030714Description: 679-85 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain -- pathology
- Brain Neoplasms -- radiotherapy
- Busulfan -- administration & dosage
- Central Nervous System Neoplasms -- drug therapy
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lymphoma -- drug therapy
- Magnetic Resonance Imaging
- Male
- Prognosis
- Radiotherapy -- adverse effects
- Stem Cell Transplantation
- Thiotepa -- administration & dosage
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.